Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Current Leases: 2018-2025

Historic Current Leases for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to $3.1 million.

  • Neurogene's Current Leases rose 7.60% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 7.60%. This contributed to the annual value of $2.9 million for FY2024, which is 15.08% up from last year.
  • Latest data reveals that Neurogene reported Current Leases of $3.1 million as of Q3 2025, which was down 0.61% from $3.1 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Current Leases peaked at $3.1 million during Q2 2025, and registered a low of $1.4 million during Q1 2023.
  • Over the past 3 years, Neurogene's median Current Leases value was $2.8 million (recorded in 2024), while the average stood at $2.5 million.
  • Data for Neurogene's Current Leases shows a peak YoY soared of 86.58% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Neurogene's Current Leases stood at $2.6 million in 2023, then grew by 15.08% to $2.9 million in 2024, then increased by 7.60% to $3.1 million in 2025.
  • Its Current Leases stands at $3.1 million for Q3 2025, versus $3.1 million for Q2 2025 and $3.0 million for Q1 2025.